Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $6.59 Analyst target: $41.00 Upside: 522.15%
Bolt Biotherapeutics, Inc., a clinical-stage immuno-oncology company, is dedicated to the discovery, development and commercialization of pharmaceutical products. The company is headquartered in Redwood city, California.
See the full interactive analysis & chart →Informational only — not investment advice.